National Health Determination under paragraph 98C(1)(b) Amendment 2015 (No. 8) (PB 80 of 2015) (Cth)
PB 80 of 2015
National Health Determination under paragraph 98C(1)(b) Amendment 2015
(No. 8)
_____________________________________________________________________
I, KYLIE JONASSON, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Instrument under paragraph 98C(1)(b) of the National Health Act 1953.
Dated 25 August 2015
KYLIE JONASSON
First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health
1 Name of Instrument
(1)This Instrument is the National Health Determination under paragraph 98C(1)(b) Amendment 2015 (No. 8).
(2)This Instrument may also be cited as PB 80 of 2015.
2 Commencement
This instrument commences on 1 September 2015.
3 Amendments to Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008)
Schedule 1 amends the Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008).
Schedule 1 Amendments
Schedule 3, after entry for Hydromorphone in the form Injection containing hydromorphone hydrochloride 500 mg in 50 mL
insert:
Lisdexamfetamine Capsule containing lisdexamfetamine dimesilate 30 mg Capsule containing lisdexamfetamine dimesilate 50 mg Capsule containing lisdexamfetamine dimesilate 70 mg
Schedule 4, entry for Glucose Indicator—Blood
omit:
Test strips, 100 (EasyMate II)
Schedule 4, omit entry for Lactulose
Schedule 4, omit entry for Rivastigmine
0
0
0